"ID","biorxiv","published","title","year","journal","doi","author","author_name","author_email","author_address","hypothesis","rationale","MR_design","outcome","outcome_info","outcome_group","outcome_definition","outcome_study","outcome_age_range","outcome_sex","outcome_n_case_current","outcome_n_control_current","outcome_n_case_og","outcome_n_control_og","outcome_n_difference_reason","outcome_health_status","outcome_population","exposure","exposure_definition","exposure_study","exposure_age","exposure_sex","exposure_n_current","exposure_n_og","exposure_n_difference_reason","exposure_health_status","exposure_population","exposure_covariates_model","exposure_genotyping_dataset","exposure_independence","exposure_pleiotropy","exposure_pvalue","exposure_palindrome","exposure_proxy","exposure_HWE","IV_single","IV_multiple","IV_GRS","n_SNP_og","n_SNP_difference_reason","power_calculation","power_calculation_how","MR_method","MR_sensitivity_method1","MR_sensitivity_method2","MR_sensitivity_method3","MR_sensitivity_method4","MR_sensitivity_method5","MR_sensitivity_method_results","IV_strength","analysis_software","analysis_programme","replication_independent","replication_subsetting","multiple_testing","exposure_units","outcome_units","effect_estimate","estimate","se","ci_percent","ci_lower","ci_upper","p","adjustment_method","p_adjusted","limitations_overall","limitations_pleiotropy","limitations_population_stratification","limitations_statistical_power","notes","ID_analysis"
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","ALT","hepatic","Excluding prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","91552",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","91552","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","MR Egger","Weighted median",NA,NA,NA,"Consistent with main analysis","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Percent mean","Difference in mean","11.49",NA,"95","7.31","15.67","Not discussed","Not discussed","Not discussed","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,337
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","lov BMI and low alcohol","hepatic","Excluding prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","1916",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","1916","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Percent mean","Difference in mean","-2.3199999999999998",NA,"95","-4.29","-0.35","Not discussed","Not discussed","Not discussed","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,340
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","lov BMI and high alcohol","hepatic","Excluding prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","44607",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","44607","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Percent mean","Difference in mean","-1.31",NA,"95","-1.88","-0.73","Not discussed","Not discussed","Not discussed","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,341
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","high BMI and low alcohol","hepatic","Excluding prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","1836",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","1836","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Percent mean","Difference in mean","-0.82",NA,"95","-2.86","1.22","Not discussed","Not discussed","Not discussed","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,342
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","high BMI and high alcohol","hepatic","Excluding prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","43193",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","43193","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Reference","Reference","Reference","Reference","Reference","Reference","Reference","Reference","Reference","Reference","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,343
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","Multivariable, one-sample","ALT","ALT","hepatic","Including prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","9255",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","9255","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Percent mean","Difference in mean","11.41",NA,"95","7.23","15.59","Not discussed","Not discussed","Not discussed","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,352
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","lov BMI and low alcohol","hepatic","Including prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","1929",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","1929","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Percent mean","Difference in mean","-2.15",NA,"95","-4.13","-0.18","Not discussed","Not discussed","Not discussed","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,355
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","lov BMI and high alcohol","hepatic","Including prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","44950",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","44950","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Percent mean","Difference in mean","-1.27",NA,"95","-1.84","-0.69","Not discussed","Not discussed","Not discussed","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,356
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","high BMI and low alcohol","hepatic","Including prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","1848",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","1848","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Percent mean","Difference in mean","-0.8",NA,"95","-2.84","1.25","Not discussed","Not discussed","Not discussed","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,357
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","high BMI and high alcohol","hepatic","Including prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","43528",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","43528","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Reference","Reference","Reference","Reference","Reference","Reference","Reference","Reference","Reference","Reference","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,358
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","alcohol = 0 units, self-report","hepatic","Including prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","8430",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","8430","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Percent mean","Difference in mean","14.03",NA,"95","2.4500000000000002","25.61","Not discussed","Not discussed","Not discussed","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,367
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","alcohol = 1-14 units, self-report","hepatic","Including prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","59136",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","59136","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Percent mean","Difference in mean","13.8",NA,"95","8.94","18.66","Not discussed","Not discussed","Not discussed","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,368
24,"yes","yes","Combined Association of Body Mass Index and Alcohol Consumption With Biomarkers for Liver Injury and Incidence of Liver Disease: A Mendelian Randomization Study
",2019,"Journal of the American Medical Association Network Open","10.1001/jamanetworkopen.2019.0305","Carter","Alice R Carter","alice.carter@bristol.ac.uk","MRC Integrative Epidemiology Unit, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom","Effect of body mass index on hepatic traits","Individually, higher body mass index (BMI) and alcohol consumption increase the risk of liver disease. Evidence of a joint association is mixed; however, previous studies have not used causal inference methods robust to confounding and reverse causation. Understanding any true effect is key to developing effective interventions to reduce liver disease","One-sample","ALT","alcohol = > 15 units, self-report","hepatic","Including prevalent cases. ICD8: 570-571.9, 155.09-155.89, 573-573.9, 785.19-785.39; ICD10: K70-70.9, K74, K74.6, K75.8, K75.9, K&6, K76.p. C22, R18","Current study","Manually fill","Manually fill","23986",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Locke 2015 BMI European adults both","18+","both","23986","322154","One-sample where they got exposure SNPs from external GWAS","Healthy","European",NA,NA,"Not discussed","Not discussed","5x10-8","Not discussed","NA - direct genotyping of selected SNPs","Yes",NA,NA,"5","77","Used top 5 strongest SNPs associated with BMI in Locke et al 2015 due to available genotyping","Not discussed","Not discussed","Two-stage-least-squares","Not discussed",NA,NA,NA,NA,"Not discussed","BMI weighted allele F statistic = 453","Not discussed","Not discussed","Not discussed","Not discussed","Not discussed","SD","Percent mean","Difference in mean","6.59",NA,"95","-4.01","17.190000000000001","Not discussed","Not discussed","Not discussed","Removal of prevalent cases should have accounted for survival bias and reverse causation. Potential for misreporting and misclassification.","Some association between BMI instruments and smoking and income, but adjustemnt did not affect results.","Population are homogenous and results unlikely to be generalizeable.","Wide confidence intervals suggest power may have been low - likely a reuslt of the small number of cases in the liver disease MR analyses.",NA,369
48,"no","yes","The Role of Adiposity in Cardiometabolic Traits: A
Mendelian Randomization Analysis",2013,"PLOS Medicine","10.1371/journal.pmed.1001474","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","Effect of body mass index on cardiometabolic traits","The association between adiposity and cardiometabolic traits is well known from epidemiological studies. Whilst the causal relationship is clear for some of these traits, for others it is not.","one-sample meta-analysis","ALT","ALT","hepatic","Not discussed","Current study","18+","Both","46754",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Current study","18+","Both","46754",NA,NA,"Healthy","European","Age, Sex","Whenever rs9939609 was not genotyped directly, we used either (i) the HapMap II CEU (European) reference panel–imputed genetic information from genome-wide association studies (http://hapmap.ncbi.nlm.nih.gov/downloads/genotypes/2008-10_phaseII/) for rs9939609 (n = 5) or (ii) genotype information from a predefined list of proxies that are in high linkage disequilibrium (LD) with rs9939609 (n = 10, r2>0.9; Table S3)",NA,"Not discussed","Not discussed",NA,"R2 > 0.9","p>0.0001","FTO (rs9939609)",NA,NA,NA,NA,"No",NA,"Inverse variance weighted (multiplicative random effects)","Not discussed",NA,NA,NA,NA,"Observational estimates were similar","Not discussed","Varied by cohort but  at least one cohort used PLINK, R, SPSS, STATA","Not discussed","Not discussed","Not discussed","No","kg/m2","U/l (ln)","beta","3.4000000000000002E-2",NA,"95","1.6E-2","5.1999999999999998E-2","2.0x10-4","None",NA,"The limitations of our study are tied to the validity of the assumptions underlying causal interpretation within MR studies.","the precise mechanism of the FTO polymorphisms is still unclear, and potential pleiotropy cannot completely be ruled out","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely","Post hoc power calculation showed that for the binary traits with non-significant IVs (CHD, ischemic stroke, and all-cause stroke), we had an 80% chance of detecting an IV estimator odds ratio (OR) of 1.08–1.09/BMI unit or higher, and a 95% chance of detecting an OR of 1.13–1.15/BMI unit or higher.",NA,760
49,"no","yes","Age- and Sex-Specific Causal Effects
of Adiposity on Cardiovascular
Risk Factors",2015,"Diabetes","10.2337/db14-0988","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","The objective of the current study was to use a Mendelian
randomization design to assess whether adiposity causally
affects known cardiovascular risk factors at a similar magnitude
in men and women and before and after 55 years
of age.","Observational studies have reported different effects of
adiposity on cardiovascular risk factors across age and
sex. Since cardiovascular risk factors are enriched in
obese individuals, it has not been easy to dissect the
effects of adiposity from those of other risk factors.","one-sample meta-analysis","ALT","natural log ALT","hepatic","Varied by cohort","Current study","<55","Both","11215",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both","<55","both","11215","249796","One sample where they took exposure SNPs from other GWAS","Healthy","European","Sex","Directly genotyped, not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes, directly genotyped proxy SNPs from a predefined list of variants that are in high linkage disequilibrium (LD) with lead SNPs were used","p>0.0001",NA,NA,"32","32",NA,"No",NA,"Inverse variance weighted (fixed effects)","Not discussed",NA,NA,NA,NA,NA,"F-statistic = 484","R 3.0.0","rmeta for random effect meta-analysis, unclear for calculating estimates","Not discussed","Not discussed","Benjamini and Hochberg (24) procedure implemented in the STATA multproc procedure to correct the level of significance to a 5% false discovery rate (FDR).","SD","SD","beta","0.22",NA,"95","0.05","0.39","0.01","5% FDR","2.1999999999999999E-2","The limitations are mainly related to the validity of the assumptions underlying causal interpretation within Mendelian randomization studies","Possible violations of the first and the third assumptions include population stratification, pleiotropic effects, canalization, epigenetic effects, and the presence of genes associated with confounders and outcomes in LD with the genetic variants used.","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely.","No formal analysis, but they do qualitatively talk about the power, e.g.: ""The sample sizes in IV analyses varied with phenotype and strata from 2,077 individuals (age ,55 years, 2-h post-OGTT glucose levels) to 67,553 individuals (nonstratified analysis, systolic blood pressure), yielding larger SEs in the smaller groups, and lower statistical power to detect causal effects and differences between strata.""","Also present results straitified by age and sex",778
49,"no","yes","Age- and Sex-Specific Causal Effects
of Adiposity on Cardiovascular
Risk Factors",2015,"Diabetes","10.2337/db14-0988","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","The objective of the current study was to use a Mendelian
randomization design to assess whether adiposity causally
affects known cardiovascular risk factors at a similar magnitude
in men and women and before and after 55 years
of age.","Observational studies have reported different effects of
adiposity on cardiovascular risk factors across age and
sex. Since cardiovascular risk factors are enriched in
obese individuals, it has not been easy to dissect the
effects of adiposity from those of other risk factors.","one-sample meta-analysis","ALT","natural log ALT","hepatic","Varied by cohort","Current study",">55","Both","12712",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both",">55","both","12712","249796","One sample where they took exposure SNPs from other GWAS","Healthy","European","Sex","Directly genotyped, not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes, directly genotyped proxy SNPs from a predefined list of variants that are in high linkage disequilibrium (LD) with lead SNPs were used","p>0.0001",NA,NA,"32","32",NA,"No",NA,"Inverse variance weighted (fixed effects)","Not discussed",NA,NA,NA,NA,NA,"F-statistic = 484","R 3.0.0","rmeta for random effect meta-analysis, unclear for calculating estimates","Not discussed","Not discussed","Benjamini and Hochberg (24) procedure implemented in the STATA multproc procedure to correct the level of significance to a 5% false discovery rate (FDR).","SD","SD","beta","−0.10",NA,"95","-0.39","0.19","0.05","5% FDR","2.1999999999999999E-2","The limitations are mainly related to the validity of the assumptions underlying causal interpretation within Mendelian randomization studies","Possible violations of the first and the third assumptions include population stratification, pleiotropic effects, canalization, epigenetic effects, and the presence of genes associated with confounders and outcomes in LD with the genetic variants used.","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely.","No formal analysis, but they do qualitatively talk about the power, e.g.: ""The sample sizes in IV analyses varied with phenotype and strata from 2,077 individuals (age ,55 years, 2-h post-OGTT glucose levels) to 67,553 individuals (nonstratified analysis, systolic blood pressure), yielding larger SEs in the smaller groups, and lower statistical power to detect causal effects and differences between strata.""","Also present results straitified by age and sex",792
49,"no","yes","Age- and Sex-Specific Causal Effects
of Adiposity on Cardiovascular
Risk Factors",2015,"Diabetes","10.2337/db14-0988","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","The objective of the current study was to use a Mendelian
randomization design to assess whether adiposity causally
affects known cardiovascular risk factors at a similar magnitude
in men and women and before and after 55 years
of age.","Observational studies have reported different effects of
adiposity on cardiovascular risk factors across age and
sex. Since cardiovascular risk factors are enriched in
obese individuals, it has not been easy to dissect the
effects of adiposity from those of other risk factors.","one-sample meta-analysis","ALT","natural log ALT","hepatic","Varied by cohort","Current study","18+","Women","14701",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both","18+","both","14701","249796","One sample where they took exposure SNPs from other GWAS","Healthy","European","Age","Directly genotyped, not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes, directly genotyped proxy SNPs from a predefined list of variants that are in high linkage disequilibrium (LD) with lead SNPs were used","p>0.0001",NA,NA,"32","32",NA,"No",NA,"Inverse variance weighted (fixed effects)","Not discussed",NA,NA,NA,NA,NA,"F-statistic = 484","R 3.0.0","rmeta for random effect meta-analysis, unclear for calculating estimates","Not discussed","Not discussed","Benjamini and Hochberg (24) procedure implemented in the STATA multproc procedure to correct the level of significance to a 5% false discovery rate (FDR).","SD","SD","beta","0.11",NA,"95","-0.04","0.26","0.14000000000000001","5% FDR","2.1999999999999999E-2","The limitations are mainly related to the validity of the assumptions underlying causal interpretation within Mendelian randomization studies","Possible violations of the first and the third assumptions include population stratification, pleiotropic effects, canalization, epigenetic effects, and the presence of genes associated with confounders and outcomes in LD with the genetic variants used.","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely.","No formal analysis, but they do qualitatively talk about the power, e.g.: ""The sample sizes in IV analyses varied with phenotype and strata from 2,077 individuals (age ,55 years, 2-h post-OGTT glucose levels) to 67,553 individuals (nonstratified analysis, systolic blood pressure), yielding larger SEs in the smaller groups, and lower statistical power to detect causal effects and differences between strata.""","Also present results straitified by age and sex",806
49,"no","yes","Age- and Sex-Specific Causal Effects
of Adiposity on Cardiovascular
Risk Factors",2015,"Diabetes","10.2337/db14-0988","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","The objective of the current study was to use a Mendelian
randomization design to assess whether adiposity causally
affects known cardiovascular risk factors at a similar magnitude
in men and women and before and after 55 years
of age.","Observational studies have reported different effects of
adiposity on cardiovascular risk factors across age and
sex. Since cardiovascular risk factors are enriched in
obese individuals, it has not been easy to dissect the
effects of adiposity from those of other risk factors.","one-sample meta-analysis","ALT","natural log ALT","hepatic","Varied by cohort","Current study","18+","Men","9226",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both","18+","both","9226","249796","One sample where they took exposure SNPs from other GWAS","Healthy","European","Age","Directly genotyped, not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes, directly genotyped proxy SNPs from a predefined list of variants that are in high linkage disequilibrium (LD) with lead SNPs were used","p>0.0001",NA,NA,"32","32",NA,"No",NA,"Inverse variance weighted (fixed effects)","Not discussed",NA,NA,NA,NA,NA,"F-statistic = 484","R 3.0.0","rmeta for random effect meta-analysis, unclear for calculating estimates","Not discussed","Not discussed","We used the Benjamini and Hochberg (24) procedure implemented in the STATA multproc procedure to correct the level of significance to a 5% false discovery rate (FDR).","SD","SD","beta","0.09",NA,"95","-0.14000000000000001","0.32","0.43","5% FDR","2.1999999999999999E-2","The limitations are mainly related to the validity of the assumptions underlying causal interpretation within Mendelian randomization studies","Possible violations of the first and the third assumptions include population stratification, pleiotropic effects, canalization, epigenetic effects, and the presence of genes associated with confounders and outcomes in LD with the genetic variants used.","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely.","No formal analysis, but they do qualitatively talk about the power, e.g.: ""The sample sizes in IV analyses varied with phenotype and strata from 2,077 individuals (age ,55 years, 2-h post-OGTT glucose levels) to 67,553 individuals (nonstratified analysis, systolic blood pressure), yielding larger SEs in the smaller groups, and lower statistical power to detect causal effects and differences between strata.""","Also present results straitified by age and sex",820
49,"no","yes","Age- and Sex-Specific Causal Effects
of Adiposity on Cardiovascular
Risk Factors",2015,"Diabetes","10.2337/db14-0988","Fall","Erik Ingelsson","erik.ingelsson@medsci.uu.se","Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden","The objective of the current study was to use a Mendelian
randomization design to assess whether adiposity causally
affects known cardiovascular risk factors at a similar magnitude
in men and women and before and after 55 years
of age.","Observational studies have reported different effects of
adiposity on cardiovascular risk factors across age and
sex. Since cardiovascular risk factors are enriched in
obese individuals, it has not been easy to dissect the
effects of adiposity from those of other risk factors.","one-sample meta-analysis","ALT","natural log ALT","hepatic","Varied by cohort","Current study","18+","Both","23927",NA,NA,NA,NA,"Healthy","European","BMI","BMI","Speliotes 2010 BMI Europeans both","18+","both","23927","249796","One sample where they took exposure SNPs from other GWAS","Healthy","European","Age, Sex","Directly genotyped, not discussed","Not discussed","Not discussed","Not discussed","Not discussed","Yes, directly genotyped proxy SNPs from a predefined list of variants that are in high linkage disequilibrium (LD) with lead SNPs were used","p>0.0001",NA,NA,"32","32",NA,"No",NA,"Inverse variance weighted (fixed effects)","Not discussed",NA,NA,NA,NA,NA,"F-statistic = 484","R 3.0.0","rmeta for random effect meta-analysis, unclear for calculating estimates","Not discussed","Not discussed","We used the Benjamini and Hochberg (24) procedure implemented in the STATA multproc procedure to correct the level of significance to a 5% false discovery rate (FDR).","SD","SD","beta","0.09",NA,"95","20.09","0.26","0.32","5% FDR","2.1999999999999999E-2","The limitations are mainly related to the validity of the assumptions underlying causal interpretation within Mendelian randomization studies","Possible violations of the first and the third assumptions include population stratification, pleiotropic effects, canalization, epigenetic effects, and the presence of genes associated with confounders and outcomes in LD with the genetic variants used.","all studies included only individuals of European ancestry. Hence, bias from population stratification is deemed unlikely.","No formal analysis, but they do qualitatively talk about the power, e.g.: ""The sample sizes in IV analyses varied with phenotype and strata from 2,077 individuals (age ,55 years, 2-h post-OGTT glucose levels) to 67,553 individuals (nonstratified analysis, systolic blood pressure), yielding larger SEs in the smaller groups, and lower statistical power to detect causal effects and differences between strata.""","Also present results straitified by age and sex",834
